Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested Capital

Immunovant (IMVT) Return on Assets (2019 - 2026)

Immunovant filings provide 7 years of Return on Assets readings, the most recent being 0.01% for Q4 2025.

  • Quarterly Return on Assets changed 0.0% to 0.01% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.01% through Dec 2025, changed 0.0% year-over-year, with the annual reading at 0.01% for FY2025, 0.0% changed from the prior year.
  • Return on Assets hit 0.01% in Q4 2025 for Immunovant, up from 0.01% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.0% in Q4 2021 and bottomed at 0.01% in Q4 2024.
  • Average Return on Assets over 5 years is 0.0%, with a median of 0.0% recorded in 2022.
  • Peak annual rise in Return on Assets hit 0bps in 2021, while the deepest fall reached 0bps in 2021.
  • Immunovant's Return on Assets stood at 0.0% in 2021, then tumbled by -81bps to 0.0% in 2022, then fell by -8bps to 0.0% in 2023, then plummeted by -68bps to 0.01% in 2024, then soared by 31bps to 0.01% in 2025.
  • Per Business Quant, the three most recent readings for IMVT's Return on Assets are 0.01% (Q4 2025), 0.01% (Q3 2025), and 0.01% (Q2 2025).